Physician

Rasham Deep S Sandhu, M.D

According to 2025 Medicare claims, Rasham Sandhu, M.D (NPI: 1285925628) practices cardiology in the Bakersfield-Delano, CA market, with the plurality of this provider's patient population coming from Kern, CA. This provider's primary affiliated billing organization is CALIFORNIA CARDIOVASCULAR INSTITUTE (NPI: 1497462659; TIN: 884143827) and primary practice location at 93312-4343. Sandhu is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Sandhu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,935 traditional Medicare patients, billed 10,408 HCPCS/CPT codes, and received $1,056,848 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 7,910 prescription claims across 1,026 beneficiaries totaling $1,211,970 in drug costs, led by Eliquis (Apixaban). DME data shows 16 claims. Open Payments data shows 104 records totaling $2,430. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $970,835 to $1,056,848. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $195,219 to $1,211,970. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $8,218 and ending at $5,712.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,383	7,776	$970,835
2016	1,531	10,607	$1,642,605
2017	1,570	12,615	$1,840,044
2018	1,610	21,118	$2,075,362
2019	1,598	23,293	$2,411,982
2020	1,773	21,256	$2,188,256
2021	1,887	24,438	$2,193,952
2022	1,902	21,106	$1,638,624
2023	1,465	8,493	$698,376
2024	1,935	10,408	$1,056,848

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	493	4,830	$195,219
2016	671	6,050	$315,127
2017	838	8,375	$462,739
2018	928	9,320	$562,735
2019	1,016	9,653	$679,274
2020	1,134	10,477	$820,956
2021	1,171	10,636	$925,624
2022	1,191	10,808	$1,109,313
2023	1,032	6,567	$860,975
2024	1,026	7,910	$1,211,970

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	19	$1,693
2016	N/R	44	$3,012
2017	N/R	22	$1,088
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	12	$24,038
2022	N/R	11	$25,479
2023	N/R	N/R	N/R
2024	N/R	16	$1,029

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	846	874	$133
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	466	466	$116
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,539	3,777	$67
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	717	798	$11
93005	Routine electrocardiogram (ecg) using at least 12 leads with tracing	671	692	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	257	13,200	$254,674
Entresto	Sacubitril/Valsartan	193	8,730	$155,564
Repatha Sureclick	Evolocumab	196	7,302	$138,750
Xarelto	Rivaroxaban	99	5,962	$110,069
Farxiga	Dapagliflozin Propanediol	116	6,150	$106,136

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	16	$1,029

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	104	$2,430	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rasham Deep S. Sandhu, M.D?

Tedicare shows public-source Medicare data for Rasham Deep S. Sandhu, M.D (NPI 1285925628), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rasham Deep S. Sandhu, M.D have ACO affiliation data?

Rasham Deep S. Sandhu, M.D is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Rasham Deep S. Sandhu, M.D?

Rasham Deep S. Sandhu, M.D is linked to CALIFORNIA CARDIOVASCULAR INSTITUTE (billing NPI 1497462659) in the available physician profile data.

Does Rasham Deep S. Sandhu, M.D have Open Payments data?

Rasham Deep S. Sandhu, M.D has 104 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.